Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva

Clinical trial NCT07672782 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07672782
Sponsor: GOG Foundation
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Vulvar Carcinoma Recurrent or Metastatic Vulvar Cancer Squamous Cell Carcinoma Vulva

Start date: 2026-11-01
Primary completion: 2029-03-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.